In total, three prognostic differentially expressed genes were identified in PACA patient plasma samples, including SMAP2, PTPN6, and EVL (Ena/VASP-like). This evidence concerns the gene SMAP2 and permanent neonatal diabetes mellitus-pancreatic and cerebellar agenesis syndrome.